Genetic basis and therapies for vascular anomalies

A Queisser, E Seront, LM Boon, M Vikkula - Circulation research, 2021 - Am Heart Assoc
Vascular and lymphatic malformations represent a challenge for clinicians. The identification
of inherited and somatic mutations in important signaling pathways, including the PI3K …

Consensus guidelines for the use and interpretation of angiogenesis assays

P Nowak-Sliwinska, K Alitalo, E Allen, A Anisimov… - Angiogenesis, 2018 - Springer
The formation of new blood vessels, or angiogenesis, is a complex process that plays
important roles in growth and development, tissue and organ regeneration, as well as …

Lymphatic malformations: genetics, mechanisms and therapeutic strategies

T Mäkinen, LM Boon, M Vikkula, K Alitalo - Circulation research, 2021 - Am Heart Assoc
Lymphatic vessels maintain tissue fluid homeostasis by returning to blood circulation
interstitial fluid that has extravasated from the blood capillaries. They provide a trafficking …

Therapeutic targeting of the angiopoietin–TIE pathway

P Saharinen, L Eklund, K Alitalo - Nature Reviews Drug Discovery, 2017 - nature.com
The endothelial angiopoietin (ANG)–TIE growth factor receptor pathway regulates vascular
permeability and pathological vascular remodelling during inflammation, tumour …

A review of mechanisms of disease across PIK3CA-related disorders with vascular manifestations

G Canaud, AM Hammill, D Adams, M Vikkula… - Orphanet Journal of …, 2021 - Springer
Background PIK3CA-related disorders include vascular malformations and overgrowth of
various tissues that are caused by postzygotic, somatic variants in the gene encoding …

Sirolimus (rapamycin) for slow-flow malformations in children: the observational-phase randomized clinical PERFORMUS trial

A Maruani, E Tavernier, O Boccara… - JAMA …, 2021 - jamanetwork.com
Importance Sirolimus is increasingly being used to treat various vascular anomalies,
although evidence of its efficacy is lacking. Objective To assess the efficacy and safety of …

Sirolimus is efficacious in treatment for extensive and/or complex slow-flow vascular malformations: a monocentric prospective phase II study

J Hammer, E Seront, S Duez, S Dupont… - Orphanet journal of rare …, 2018 - Springer
Background Extensive and complex vascular malformations often cause chronic pain and
severe functional restraint. Conventional treatments, such as surgery and/or sclerotherapy …

Somatic activating PIK3CA mutations cause venous malformation

N Limaye, J Kangas, A Mendola, C Godfraind… - The American Journal of …, 2015 - cell.com
Somatic mutations in TEK, the gene encoding endothelial cell tyrosine kinase receptor TIE2,
cause more than half of sporadically occurring unifocal venous malformations (VMs). Here …

Tie1 controls angiopoietin function in vascular remodeling and inflammation

EA Korhonen, A Lampinen, H Giri… - The Journal of …, 2016 - Am Soc Clin Investig
The angiopoietin/Tie (ANG/Tie) receptor system controls developmental and tumor
angiogenesis, inflammatory vascular remodeling, and vessel leakage. ANG1 is a Tie2 …

Opposing actions of angiopoietin-2 on Tie2 signaling and FOXO1 activation

M Kim, B Allen, EA Korhonen… - The Journal of …, 2016 - Am Soc Clin Investig
Angiopoietin-2 (ANG2) regulates blood vessel remodeling in many pathological conditions
through differential effects on Tie2 signaling. While ANG2 competes with ANG1 to inhibit …